Home5VB • FRA
add
Nykode Therapeutics ASA
Previous close
€0.16
Day range
€0.15 - €0.15
Year range
€0.086 - €0.29
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 118.00K | -82.26% |
Operating expense | 6.40M | -59.04% |
Net income | -3.66M | 62.39% |
Net profit margin | -3.10K | -111.94% |
Earnings per share | -0.10 | 69.41% |
EBITDA | -6.10M | 58.71% |
Effective tax rate | 26.45% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 63.93M | -48.70% |
Total assets | 105.70M | -37.24% |
Total liabilities | 6.44M | -74.99% |
Total equity | 99.25M | — |
Shares outstanding | 326.55M | — |
Price to book | 0.54 | — |
Return on assets | -14.44% | — |
Return on capital | -15.09% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.66M | 62.39% |
Cash from operations | -6.02M | 52.80% |
Cash from investing | 7.00K | -99.35% |
Cash from financing | -333.00K | -8.82% |
Net change in cash | -6.06M | 49.17% |
Free cash flow | -4.40M | 45.49% |
About
Founded
2006
Website
Employees
62
